Yifang Biotechnology (688382.SH): Net loss of 246 million yuan in 2024, narrowing losses year-on-year.

Yifang Biotechnology (688382.SH) released its 2024 annual performance report, reporting that the company achieved operating income of 169 million yuan during the reporting period, a decrease of 8.85% year-on-year; net loss attributable to shareholders of the listed company was 246 million yuan, a narrowing of losses year-on-year; net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 255 million yuan, a narrowing of losses year-on-year; basic loss per share was 0.43 yuan/share.